These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1904664)

  • 1. Cyclosporine's dual mechanism of action in inhibiting generation of the cytoplasmic activation signal and the nuclear response thereto.
    Citterio F; Kahan BD
    Transplantation; 1991 Jun; 51(6):1248-57. PubMed ID: 1904664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
    Citterio F; Kahan BD
    Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of prolyl-peptidyl isomerase to mediate cyclosporine suppression of intracellular activation signal generation.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1991 Feb; 51(2):509-13. PubMed ID: 1994547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation.
    Vathsala A; Chou TC; Kahan BD
    Transplantation; 1990 Feb; 49(2):463-72. PubMed ID: 1689520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes.
    Prince HE; John JK
    Immunol Invest; 1986 Aug; 15(5):463-72. PubMed ID: 3096881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
    Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
    J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
    Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H
    Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro immunosuppressive properties of cyclosporine metabolites.
    Freed BM; Rosano TG; Lempert N
    Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intra-subject variation of the suppression of mitogen-induced proliferation of human lymphocytes by cyclosporin-A: reduction of response with delayed addition may be relevant to timing of therapy.
    Spiers EM; Beck JS
    Int J Immunopharmacol; 1991; 13(2-3):245-50. PubMed ID: 2071297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.
    Kay JE; Benzie CR
    Immunology; 1986 Feb; 57(2):195-9. PubMed ID: 3485075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis.
    Kermani-Arab V; Salehmoghaddam S; Danovitch G; Hirji K; Rezai A
    Transplantation; 1985 Apr; 39(4):439-42. PubMed ID: 3920796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.